Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2023-05-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-059162
- Form type
- SC 13G
- Filer
- Paradigm Biocapital Advisors LP
- CIK
- CIK 1855655
- Filed
- May 11, 2023
- Reporting period
- May 01, 2023
- Description
- Schedule 13G beneficial ownership